utrigenomic risk profiles for Mild Cognitive Impairment, Alzheimer's disease and Parkinson's disease

Not Applicable

• Conditions: Neurodegenerative diseases; eurodegenerative diseases; Neurological - Neurodegenerative diseases

• Registration Number: ACTRN12610000090011
• Lead Sponsor: Commonwealth Scientific and Industrial Research Organisation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-01-27
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 900

Inclusion Criteria

Control Group:
Male or female, Aged 55 and above, Not clinically diagnosed with mild cognitive impairment, Alzheimer's disease and Parkinson's, No family history of mild cognitive impairment, Alzheimer's disease and Parkinson's disease
Mild cognitive impairment Group:
Male or female, Aged 55 and above, Clinically diagnosed with mild cognitive impairment
Alzheimer's disease Group:
Male or female, Aged 55 and above, Clinically diagnosed with Alzheimer's disease
Parkinson's disease Group:
Male or female, Aged 55 or above, Clinically diagnosed with Parkinson's disease

Exclusion Criteria

Control Group:
Patients who are undergoing chemotherapy,radiotherapy treatment for cancer, patients that are supplementing with above recommended dietary intakes of micronutrients associated with genome maintenance
Mild cognitive impairment Group:
Patients who are undergoing chemotherapy, radiotherapy treatment for cancer, patients that are supplementing with above recommended dietary intakes of micronutrients associated with genome maintenance
Alzheimer's disease Group:
Patients who are undergoing chemotherapy, radiotherapy treatment for cancer, patients that are supplementing with above recommended dietary intakes of micronutrients associated with genome maintenance
Parkinson's disease Group:
Patients who are undergoing chemotherapy, radiotherapy treatment for cancer, patients that are supplementing with above recommended dietary intakes of micronutrients associated with genome maintenance

Study & Design

• Study Type: Observational
• Study Design: Not specified